The place of the third generation sulfonylurea glimepiride in modern therapy of type 2 diabetes mellitus
The article considers the pharmacological and clinical aspects of the use of glimepiride, a third generation sulfonylurea, in modern therapy of type 2 diabetes mellitus. The drug is characterized by proven efficacy and safety, economical affordability, a number of favorable non-pancreatic effects, i...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publishing House Zaslavsky
2019-03-01
|
| Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
| Subjects: | |
| Online Access: | http://iej.zaslavsky.com.ua/article/view/166106 |
| Summary: | The article considers the pharmacological and clinical aspects of the use of glimepiride, a third generation sulfonylurea, in modern therapy of type 2 diabetes mellitus. The drug is characterized by proven efficacy and safety, economical affordability, a number of favorable non-pancreatic effects, including cardioprotective properties. Everything mentioned above allows us to recommend it confidently for the treatment of type 2 diabetes mellitus. |
|---|---|
| ISSN: | 2224-0721 2307-1427 |